[1] Bross MH, Soch K, Morales R, et al.Vibrio vulnificus infection: diagnosis and treatment[J].Am Fam Physician,2007, 76(4):539-44. [2] 胡国新, 卢中秋.七种抗菌药物对创伤弥菌感染小鼠实验治疗的时效和量效关系[J].中国临床药理学与治疗学, 2003, 8(1):81-85. [3] 李萌芳, 梁欢, 卢中秋, 等.治疗前后酒精灌胃大鼠创伤弧菌脓毒症肝组织Toll 样受体等的变化[J].中华预防医学杂志, 2008, 42(9):658-662. [4] Chiang SR, Chuang YC.Vibrio vulnificus infection:clinical manifestations, pathogenesis, and antimicrobial therapy[J].J Microbiol Immunol Infect, 2003, 36(2):81-88. [5] Chang AK, Kim HY, Park JE, et al.Vibrio vulnificus secretes a broad-specificity metalloprotease capable of interfering with blood homeostasis through prothrombin activation and fibrinoly sis[J].J Bacteriol, 2005, 187(20):6909-6916. [6] 胡森.MODS 的诊断[M] 盛志勇, 胡森, 主编.多器官功能障碍综合征.1版.北京:科学出版社, 1999:185-188. [7] Gulig PA, Bourdage KL, Starks AM.et al.Molecular pathogenesis of vibrio vulnificus[J].J Microbiol, 2005, 43(1):118-31. [8] Rho HW, Choi MJ, Lee JN, et al. Cytotoxic mechanism of vibrio vulnificus cytolysin in CPAE cells[J].Life Sciences,2002, 70(6):1923-1934. [9] Nakafusa J, Misago N, Miura Y, et al.The importance of serum creatine phosphokinase level in the early diagnosis, and as a prognostic factor of Vibrio vulnificus infection [J].Br J Dermatol, 2001, 145(2):280-284. [10] 余, 刘先哲, 邓群, 等.血栓调节蛋白和基质金属蛋白酶在脓毒症及多器官功能障碍综合征中的意义[J].中华急诊医学杂志, 2006, 15(6):558-561. [11] Hoffmann U, Bertsch T, Dvortsak E, et al.Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis:prognostic value of TIMP-1 in severe sepsis[J]. Scand J Infect Dis, 2006, 38(10):867-872. [12] Castellheim A, Thorgersen EB, Hellerud BC, et al. New biomarkers in an acute model of live Escherichia coli-induced sepsis in pigs[J].Scand J Immunol, 2008, 68(1):75-84. [13] Rhee JW, Lee KW, Sohn WJ, et al.Regulation of matrix metalloproteinase-9 gene expression and cell migration by NF-kappa B in response to CpG-oligodeoxynucleotides in RAW 264.7 cells[J].Mol Immunol, 2007, 44(6):1393-1400. [14] 卢中秋, 邱俏檬, 李海燕, 等.创伤弧菌脓毒症病理组织学及血清细胞因子动态变化研究[J].浙江医学,2007, 29(1):23-25. [15] 卢中秋, 梁欢, 李萌芳, 等.创伤弧菌脓毒症大鼠肝组织核转录因子-κB 活性表达及抗菌药物的影响[J].中国急救医学, 2007, 27(12):1090-1093. [16] Martin EL, Moyer BZ, PapeMC, et al.Negative impact of tissue inhibitor of metalloproteinase-3 null mutation on lung Clin Pharmacol Ther 2009 Apr;14(4)structure and function in response to sepsis[J].Am J Physiol Lung Cell Mol Physiol, 2003, 285(6):L1222-L1232. [17] Pagenstecher A, Stalder AK, Kincaid CL, et al.Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide induced endotoxemia in mice[J].Am J Pathol, 2000, 157(1):197-210. [18] Clark IM, Swingler TE, Sampieri CL, et al.The regulation of matrix metalloproteinases and their inhibitors[J]. Int J Biochem Cell Biol, 2008, 40(67):1362-1378. |